✦ LIBER ✦

Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?

✍ Scribed by Toshio Miyata; Takashi Dan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of Advanced Glycation End Pro

✍ Toshio Miyata; Yuko Izuhara 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Modulation of Soluble Receptor for Advan

✍ Forbes, J. M. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 353 KB

Anti-Hypertensive Agents Inhibit In Vivo

✍ Nangaku, M. 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 710 KB

An α-glucosidase inhibitor, acarbose tre

✍ Miwako Tsunosue; Naomi Mashiko; Yhukou Ohta; Yoshito Matsuo; Kouichi Ueda; Masay 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 150 KB

Peroxisome proliferator-activated recept

✍ Yao-Jen Liang; Siang-An Chen; Jhih-Hao Jian 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Efficacy of alogliptin, a dipeptidyl pep

✍ Sakata, Koji; Hayakawa, Manabu; Yano, Yuichiro; Tamaki, Noboru; Yokota, Naoto; E 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB